2,4,6-Trichloropyrido[3,4-d]pyrimidine, 95%, 100mg

Benzyl 3-oxo-4-(prop-2-yn-1-yl)piperazine-1-carboxylate, 97%, 500mg

(1S,2S)-(+)-N-(4-Toluenesulphonyl)-1,2-diphenylethylenediamine, 98.0%, 1g

1-(5-Trifluoromethyl-pyridin-2-yl)-ethanone, 95.0%, 1g

3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 250mg

h-gln-otbu.hcl, 98.0%, 5g

1-Methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one, 98%, 100mg

Dimethyl 3-aminothiophene-2,5-dicarboxylate, 98%, 1g

C-Pyridin-4-yl-methylamine hydrochloride, 95.0%, 5g

2-(3,4-Dichlorophenoxy)acetohydrazide, 95.0%, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(furan-2-yl)propanoic acid, 95.0%, 5g

Granulés d'or, min 99,95 %, 1-6 mm, 1 g, emballage en verre

(S)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)PYRROLIDIN-2-ONE, 95.0%, 500mg